These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 28032208)
21. Growth hormone therapy in a girl with Turner syndrome and diabetes type 1 - case report. Obara-Moszynska M; Banaszak M; Niedziela M Pediatr Endocrinol Diabetes Metab; 2015; 20(2):75-81. PubMed ID: 26615017 [TBL] [Abstract][Full Text] [Related]
22. Non-conventional growth hormone therapy in Turner syndrome: the United States experience. Rosenfeld RG Horm Res; 1990; 33(2-4):137-40; discussion 140-2. PubMed ID: 2210618 [TBL] [Abstract][Full Text] [Related]
24. [Human growth hormone and Turner syndrome]. Sánchez Marco SB; de Arriba Muñoz A; Ferrer Lozano M; Labarta Aizpún JI; Garagorri Otero JM An Pediatr (Barc); 2017 Feb; 86(2):81-86. PubMed ID: 27179405 [TBL] [Abstract][Full Text] [Related]
25. Turner syndrome in Albania and the efficacy of its treatment with growth hormone. Hoxha P; Babameto-Laku A; Vyshka G; Gjoka K; Minxuri D; Myrtaj E; Çakërri L J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1227-34. PubMed ID: 26181044 [TBL] [Abstract][Full Text] [Related]
26. [Rapidly progressive puberty in a patient with mosaic Turner syndrome: a case report and literature review]. Liang Y; Wei H; Yu X; Huang W; Luo XP Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):125-130. PubMed ID: 28173651 [No Abstract] [Full Text] [Related]
27. Growth hormone therapy in patients with Turner syndrome. Haeusler G Horm Res; 1998; 49 Suppl 2():62-6. PubMed ID: 9730674 [TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma and congenital absence of the portal vein in a child receiving growth hormone therapy for turner syndrome. Morotti RA; Killackey M; Shneider BL; Repucci A; Emre S; Thung SN Semin Liver Dis; 2007 Nov; 27(4):427-31. PubMed ID: 17979078 [TBL] [Abstract][Full Text] [Related]
29. Absence of growth hormone effects on cognitive function in girls with Turner syndrome. Ross JL; Feuillan P; Kushner H; Roeltgen D; Cutler GB J Clin Endocrinol Metab; 1997 Jun; 82(6):1814-7. PubMed ID: 9177388 [TBL] [Abstract][Full Text] [Related]
30. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome. Davenport ML Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135 [TBL] [Abstract][Full Text] [Related]
31. Management of Turner syndrome in adult life and beyond. Castelo-Branco C Maturitas; 2014 Dec; 79(4):471-5. PubMed ID: 25438673 [TBL] [Abstract][Full Text] [Related]
37. Growth hormone treatment in Japan: past, present, and future. Tanaka T Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():89-97. PubMed ID: 23330250 [TBL] [Abstract][Full Text] [Related]
38. The current management of Turner Syndrome. Kriksciuniene R; Zilaitiene B; Verkauskiene R Minerva Endocrinol; 2016 Mar; 41(1):105-21. PubMed ID: 26878561 [TBL] [Abstract][Full Text] [Related]
39. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both]. Starzyk J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336 [TBL] [Abstract][Full Text] [Related]
40. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome. Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]